Orbimed Advisors - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 3 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2017$2,936,000
-42.5%
2,207,245
-32.1%
0.03%
-47.2%
Q2 2017$5,103,000
-51.4%
3,250,3000.0%0.05%
-55.5%
Q1 2017$10,498,000
+139.2%
3,250,3000.0%0.12%
+112.5%
Q4 2016$4,388,000
-13.5%
3,250,3000.0%0.06%
-3.4%
Q3 2016$5,070,000
+17.3%
3,250,3000.0%0.06%
+28.9%
Q2 2016$4,323,000
-78.0%
3,250,300
-12.7%
0.04%
-78.2%
Q1 2016$19,623,000
-43.4%
3,723,528
-15.7%
0.21%
-34.4%
Q4 2015$34,668,000
-7.1%
4,416,3000.0%0.31%
-16.7%
Q3 2015$37,318,000
-22.8%
4,416,3000.0%0.38%
+6.2%
Q2 2015$48,358,000
-18.9%
4,416,300
+3.5%
0.36%
-30.3%
Q1 2015$59,623,000
-25.5%
4,264,900
-10.0%
0.51%
-33.5%
Q4 2014$80,006,000
+25.9%
4,736,9000.0%0.76%
+15.2%
Q3 2014$63,569,000
+5.3%
4,736,9000.0%0.66%
-6.3%
Q2 2014$60,348,000
+7.1%
4,736,9000.0%0.71%
+2.3%
Q1 2014$56,322,000
-14.9%
4,736,900
-1.2%
0.69%
-28.8%
Q4 2013$66,209,000
-19.9%
4,794,300
+1.1%
0.97%
-34.0%
Q3 2013$82,664,000
+12.9%
4,742,600
+4.9%
1.48%
-5.0%
Q2 2013$73,201,0004,520,8001.55%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
BVF INC/IL 9,766,508$19,826,0002.39%
PLATINUM INVESTMENT MANAGEMENT LTD 1,286,032$2,610,0000.07%
Clear Harbor Asset Management, LLC 153,800$312,0000.06%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 219,652$445,0000.03%
Rock Springs Capital Management LP 270,000$548,0000.02%
Alambic Investment Management, L.P. 77,665$158,0000.02%
Marshall Wace North America L.P. 1,173,515$2,382,0000.01%
Baker Brothers Advisors 580,400$1,178,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 459,000$932,0000.01%
Intellectus Partners, LLC 13,000$26,0000.01%
View complete list of INFINITY PHARMACEUTICALS INC shareholders